Share Price:

APNASPENAspen Pharmacare Hldgs21701-219 (-1.00%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Aspen Trading Statement

APN – Aspen Pharmacare Holdings Limited – Trading statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN & ISIN: ZAE000066692 (“Aspen”) Trading statement Aspen’s shareholders are hereby advised that diluted normalised headline earnings per share from continuing operations, headline earnings per share (“HEPS”) and earnings per… Continue reading Aspen Trading Statement

Aspen Global acquires Australian product portfolio for R2.2 billion

The Aspen Group (“Aspen”) is pleased to announce that Aspen Global Incorporated (“Aspen Global”), a wholly owned subsidiary of Aspen Holdings, has reached agreement with GlaxoSmithKline plc (“GSK”) for the acquisition of a portfolio of 25 established pharmaceutical products (“the Products”) which are distributed in Australia (“the Transaction”). The Transaction consideration is GBP 172 million… Continue reading Aspen Global acquires Australian product portfolio for R2.2 billion

Judy Dlamini, Aspen Chairman’s Upper Echelon interview

“I actually want to work until the very last day of my life”, Judy Dlamini ALEC HOGG: Upper Echelon is brought to you by Deloitte – for innovative thinking and thorough strategic planning turn to Deloitte. In our Upper Echelon this week, Judy Dlamini, chair of Mbekani Investment Holdings and better known through her chair… Continue reading Judy Dlamini, Aspen Chairman’s Upper Echelon interview

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.